Medicine & Life Sciences
Poly(ADP-ribose) Polymerase Inhibitors
92%
Ovarian Neoplasms
63%
rucaparib
41%
Heterografts
27%
Genetic Recombination
22%
Poly (ADP-Ribose) Polymerase-1
21%
Irinotecan
18%
DNA
12%
Topoisomerase I Inhibitors
11%
DNA Repair Enzymes
10%
Phase II Clinical Trials
9%
Polyethylene Glycols
8%
Molecular Biology
6%
Bone Marrow
5%
Agriculture & Biology
ovarian neoplasms
100%
chemosensitization
25%
homologous recombination
23%
NAD ADP-ribosyltransferase
20%
DNA
10%
DNA topoisomerase
9%
genomics
8%
DNA repair
7%
clinical trials
7%
resistance mechanisms
7%
nanoparticles
6%
polyethylene glycol
6%
neoplasm cells
6%
therapeutics
5%
neoplasms
5%
cell lines
5%